Phase II Clinical Trial for Inflammatory Bowel Disease, Athersys (ATHX)
November 8th, 2010
No comments
The FDA has authorized commencement of a Phase II clinical trial evaluating the safety and efficacy of administration of MultiStem(R), Read more…
Categories: IBD Phase II Clinical Trial, NASDAQ: ATHX, Stem Cell Technology
